0001209191-18-025141.txt : 20180417
0001209191-18-025141.hdr.sgml : 20180417
20180417142706
ACCESSION NUMBER: 0001209191-18-025141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180417
FILED AS OF DATE: 20180417
DATE AS OF CHANGE: 20180417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Motahari Saeed
CENTRAL INDEX KEY: 0001704399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 18758653
MAIL ADDRESS:
STREET 1: C/O INSYS THERAPEUTICS, INC.
STREET 2: 1333 SOUTH SPECTRUM BLVD, SUITE 100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-17
0
0001516479
Insys Therapeutics, Inc.
INSY
0001704399
Motahari Saeed
C/O INSYS THERAPEUTICS, INC.
1333 SOUTH SPECTRUM BLVD, SUITE 100
CHANDLER
AZ
85286
1
1
0
0
President & CEO
Common Stock
2018-04-17
4
A
0
11000
0.00
A
26400
D
Restricted Stock Units
2018-04-17
4
D
0
11000
0.00
D
Common Stock
11000
22000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On April 17, 2017, the Reporting Person received a 33,000 share restricted stock unit award ("RSUs"). The RSUs vest in 3 equal annual installments beginning on April 17, 2018 and will be fully vested on April 17, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.
/s/ Andrew Long, Attorney-in-fact
2018-04-17